Multiple public databases were used to analyze the differential expression of TUBA1C and its prognostic role in BLCA, identify likely oncogenic pathways in BLCA based on GO and KEGG analysis, and discuss the correlations of TUBA1C with tumor immunity and drug response. The gene discussed is TUBA1C; the disease is neoplasm.